The Impact of Diabetes

With the prevalence of diabetes continuing to grow in many countries, it is one of the most serious chronic health challenges we face today.

Approximately

MILLION
adults worldwide have diabetes.

Type 2 diabetes accounts for approximately
%
of all cases of diagnosed diabetes in adults.

Diabetes is the
th
leading cause of death in the U.S. and the eighth worldwide.

Diabetes is one of Merck’s top therapeutic priorities and a point of passion for many colleagues at Merck, both personally and professionally.

Karen, a Merck employee, shares her own experience living with type 2 diabetes.

LEADERSHIP THROUGH INNOVATION AND COLLABORATION

Advancements in diabetes research are making a remarkable difference for patients, but there is much more work to be done. At Merck, we strive for scientific excellence and innovation in all stages of diabetes research, from discovery to rigorous research of medicines once approved. I am proud to be part of a research team that is committed to doing something truly meaningful to help people with diabetes.
Sam Engel
associate vice president, Merck Clinical Research
Diabetes and Endocrinology
Because diabetes is complex and a growing health challenge, we are committed to collaborating globally with other healthcare innovators, and mobilizing our own talent throughout the company, to advance the care of people living with diabetes.
Rob Rode
senior vice president, general manager
Diabetes and Cardiovascular

MAKE THE COMMITMENT TO GET TO YOUR A1C GOAL

America's Diabetes Challenge: Get to Your Goals is a Merck-sponsored program created with the American Diabetes Association® and iHeart Media to raise awareness among people with type 2 diabetes about the importance of working with their doctors to set and reach their A1C goals. The program also aims to help people learn if they are at risk of low blood glucose and how to help reduce that risk.

VOICES OF AMERICA'S DIABETES CHALLENGE

S. Epatha Merkerson

Tim McGraw

Chef Leticia Moreinos Schwartz

 

Helping to Reduce Health Disparities in Diabetes

In 2009, the Merck Foundation, a U.S.-based, private foundation, launched the Alliance to Reduce Disparities in Diabetes with a commitment of $15 million to address the growing problem of healthcare disparities related to type 2 diabetes in the U.S. among low-income and underserved adult populations.

An evaluation of programs within the Alliance to Reduce Disparities in Diabetes revealed that a new model of chronic disease management for vulnerable populations with diabetes shows significant promise.

LEARN MORE

MORE ABOUT DIABETES

Changing the Statistics: A Commitment to Diabetes Research
A Point of View by Dr. Sam Engel

LEARN MORE

Understanding Diabetes
Diabetes is a chronic disease and a growing health issue.

LEARN MORE

America's Diabetes Challenge
People with type 2 diabetes should work with their doctors to set individual goals to manage the ABCs of diabetes.

LEARN MORE